Clinical Trial Update: Study of Cardiovascular Disease and Obstructive Sleep Apnea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on cardiovascular disease and obstructive sleep apnea has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obstructive Sleep Apnea

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Severe Obstructive Sleep Apnea (Apnea Hypopnea Index > 30 Events/Hour), Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-08-14